Utah Medical Products UTMD Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount at other companies
Other financials
Where this comes from
Reported directly by Utah Medical Products in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate.
The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Utah Medical Products's effective income tax rate reconciliation at federal statutory income tax rate, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Utah Medical Products's effective income tax rate reconciliation at federal statutory income tax rate, amount?
- Utah Medical Products (UTMD) reported effective income tax rate reconciliation at federal statutory income tax rate, amount of $619.25K in Q4 2025.
- How has Utah Medical Products's effective income tax rate reconciliation at federal statutory income tax rate, amount changed year-over-year?
- Utah Medical Products's effective income tax rate reconciliation at federal statutory income tax rate, amount decreased by 77.8% year-over-year, from $2.79M to $619.25K.
- What is the long-term trend for Utah Medical Products's effective income tax rate reconciliation at federal statutory income tax rate, amount?
- Over 2 years (2021 to 2025), Utah Medical Products's effective income tax rate reconciliation at federal statutory income tax rate, amount has grown at a -0.9% compound annual growth rate (CAGR), from $2.52M to $2.48M.
- What does effective income tax rate reconciliation at federal statutory income tax rate, amount mean?
- This metric represents the theoretical income tax expense calculated by applying the statutory federal tax rate to the company's pre-tax income. It serves as the baseline for the tax reconciliation process, allowing investors to see how actual tax expenses deviate from the standard rate due to various credits, deductions, and jurisdictional differences. It is fundamental for evaluating the company's tax management strategy.